| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12028-010-9474-7 |
| P698 | PubMed publication ID | 21210305 |
| P50 | author | Sang-Bae Ko | Q60983867 |
| J. Michael Schmidt | Q43182649 | ||
| P2093 | author name string | Christine Lesch | |
| Luis Fernandez | |||
| Jan Claassen | |||
| H Alex Choi | |||
| Kiwon Lee | |||
| Neeraj Badjatia | |||
| Stephan A Mayer | |||
| Rishi Malhotra | |||
| Mary Presciutti | |||
| Emily Gilmore | |||
| Amanda M Carpenter | |||
| P2860 | cites work | Propofol linearly reduces the vasoconstriction and shivering thresholds | Q46430350 |
| Efficacy of prophylactic ketamine in preventing postoperative shivering | Q46453470 | ||
| Meperidine decreases the shivering threshold twice as much as the vasoconstriction threshold | Q46655296 | ||
| Metabolic benefits of surface counter warming during therapeutic temperature modulation | Q48650654 | ||
| Ondansetron given before induction of anesthesia reduces shivering after general anesthesia | Q51399935 | ||
| Evaluation of a forced-air system for warming hypothermic postoperative patients | Q51737194 | ||
| Effect of paracetamol (acetaminophen) and ibuprofen on body temperature in acute ischemic stroke PISA, a phase II double-blind, randomized, placebo-controlled trial [ISRCTN98608690] | Q24806469 | ||
| Dantrolene reduces the threshold and gain for shivering | Q34583099 | ||
| Acquired Neuromuscular Disorders in the Intensive Care Unit | Q35548943 | ||
| Hyperthermia and fever control in brain injury | Q37523048 | ||
| Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study | Q39923980 | ||
| Effect of shivering on brain tissue oxygenation during induced normothermia in patients with severe brain injury | Q40377289 | ||
| Metabolic impact of shivering during therapeutic temperature modulation: the Bedside Shivering Assessment Scale | Q40407087 | ||
| Acetaminophen for altering body temperature in acute stroke: a randomized clinical trial | Q40590713 | ||
| Effect of paracetamol (acetaminophen) on body temperature in acute ischemic stroke: a double-blind, randomized phase II clinical trial | Q40600133 | ||
| Meperidine and skin surface warming additively reduce the shivering threshold: a volunteer study | Q41869387 | ||
| Buspirone and Meperidine Synergistically Reduce the Shivering Threshold | Q43781345 | ||
| Meperidine exerts agonist activity at the alpha(2B)-adrenoceptor subtype | Q44096133 | ||
| Dexmedetomidine and Meperidine Additively Reduce the Shivering Threshold in Humans | Q44400117 | ||
| Magnesium sulfate increases the rate of hypothermia via surface cooling and improves comfort | Q45025353 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 389-394 | |
| P577 | publication date | 2011-06-01 | |
| P1433 | published in | Neurocritical Care | Q15745303 |
| P1476 | title | Prevention of shivering during therapeutic temperature modulation: the Columbia anti-shivering protocol | |
| P478 | volume | 14 |
| Q38850728 | "Cool" Topic: Feeding During Moderate Hypothermia After Intracranial Hemorrhage |
| Q64060173 | A New Vision for Therapeutic Hypothermia in the Era of Targeted Temperature Management: A Speculative Synthesis |
| Q38114438 | Advances in the Critical Care Management of Ischemic Stroke |
| Q97429930 | Comparison of a Continuous Noninvasive Temperature to Monitor Core Temperature Measures During Targeted Temperature Management |
| Q38241341 | Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care : a statement for healthcare professionals from the Neurocritical Care Society and the European Society of Inte |
| Q38248160 | Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care: a statement for healthcare professionals from the Neurocritical Care Society and the European Society of Inten |
| Q42213307 | Current Advances in the Use of Therapeutic Hypothermia |
| Q35734916 | Dexmedetomidine Reduces Shivering during Mild Hypothermia in Waking Subjects |
| Q39067987 | Drug Interactions in Neurocritical Care |
| Q86077961 | Effect of Ondansetron on Postoperative Shivering After Craniotomy |
| Q47253224 | Esophageal Cooling Device Versus Other Temperature Modulation Devices for Therapeutic Normothermia in Subarachnoid and Intracranial Hemorrhage |
| Q39865191 | Evaluation of advanced cooling therapy's esophageal cooling device for core temperature control |
| Q37343414 | Extended Use of Hypothermia in Elderly Patients with Malignant Cerebral Edema as an Alternative to Hemicraniectomy |
| Q38581572 | First Use of a New Device for Administration of Buspirone and Acetaminophen to Suppress Shivering During Therapeutic Hypothermia |
| Q48966999 | Fluid responsiveness and brain tissue oxygen augmentation after subarachnoid hemorrhage |
| Q92451614 | High Quality Targeted Temperature Management (TTM) After Cardiac Arrest |
| Q47908860 | Hunt-Hess 5 subarachnoid haemorrhage presenting with cardiac arrest is associated with larger volume bleeds |
| Q37988812 | Hypothermia for acute brain injury—mechanisms and practical aspects |
| Q38117714 | Hypothermia in Neurocritical Care |
| Q58606531 | Infants Uniquely Express High Levels of RBM3 and Other Cold-Adaptive Neuroprotectant Proteins in the Human Brain |
| Q38223076 | Moderate-dose sedation and analgesia during targeted temperature management after cardiac arrest |
| Q38260268 | Monitoring inflammation (including fever) in acute brain injury |
| Q39154051 | Normothermia and Stroke. |
| Q45997274 | Pharmacologic evaluation of shivering management in neurologically injured patients utilizing therapeutic normothermia. |
| Q52685458 | Precise Control of Target Temperature Using N6-Cyclohexyladenosine and Real-Time Control of Surface Temperature |
| Q52603578 | Prognostic Value of the Neurological Examination in Cardiac Arrest Patients After Therapeutic Hypothermia. |
| Q48964653 | Reduced brain/serum glucose ratios predict cerebral metabolic distress and mortality after severe brain injury |
| Q38384840 | Results of the ICTuS 2 Trial (Intravascular Cooling in the Treatment of Stroke 2). |
| Q47248141 | Shivering Treatments for Targeted Temperature Management: A Review. |
| Q46180660 | Shivering: scores and protocols. |
| Q33848917 | Targeted temperature management in neurological intensive care unit |
| Q48015342 | The Implementation of Targeted Temperature Management: An Evidence-Based Guideline from the Neurocritical Care Society |
| Q36493587 | The critical care management of poor-grade subarachnoid haemorrhage |
| Q38029928 | Therapeutic Hypothermia for Traumatic Brain Injury |
| Q40221476 | Therapeutic temperature modulation for fever after intracerebral hemorrhage |
| Q89443812 | Variation in Sedation and Neuromuscular Blockade Regimens on Outcome After Cardiac Arrest |
Search more.